Advanced Life Sciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1998-01-01
- Employees
- 1
- Market Cap
- -
Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2010-02-03
- Lead Sponsor
- Advanced Life Sciences, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00701987
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Advanced Life Sciences, Inc.
- Target Recruit Count
- 522
- Registration Number
- NCT00336544
- Locations
- 🇺🇸
ISRAEL - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸PERU - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸POLAND - Advanced Life Sciences, Woodridge, Illinois, United States
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Advanced Life Sciences, Inc.
- Target Recruit Count
- 584
- Registration Number
- NCT00336505
- Locations
- 🇺🇸
USA - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸SOUTH AFRICA - Advanced Life Sciences, Woodridge, Illinois, United States
🇺🇸CANADA - Advanced Life Sciences, Woodridge, Illinois, United States
© Copyright 2024. All Rights Reserved by MedPath